Arrhythmia Research Technology Inc. (HRT) Financials Nov 14, 2014, 1:09 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Arrhythmia Research Technology Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 21.14M 23.36M 24.26M 20.64M 21.34M
Cost of Goods Sold (COGS) incl. D&A 17.56M 18.72M 19.65M 17.85M 18.31M
COGS excluding D&A 16.16M 17.34M 18.05M 16.43M 16.86M
Depreciation & Amortization Expense 1.39M 1.37M 1.6M 1.42M 1.44M
Depreciation - - - 1.41M 1.44M
Amortization of Intangibles - - - 7,056 4,840
Gross Income 3.58M 4.64M 4.61M 2.79M 3.03M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.03M 3.99M 5.74M 4.53M 3.99M
Research & Development 241,494 254,501 461,225 510,463 335,309
Other SG&A 2.79M 3.73M 5.28M 4.02M 3.65M
Other Operating Expense 0 0 0 0 0
Unusual Expense - 80,000 238,318 1.48M -
EBIT after Unusual Expense - (80,000) (238,318) (1.48M) -
Non Operating Income/Expense (9,325) 112,813 7,160 (9,319) 25,646
Non-Operating Interest Income 12,082 11,850 11,030 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 31,699 0 0 23,881 319,395
Gross Interest Expense 31,699 0 0 23,881 319,395
Interest Capitalized 0 - 0 0 0
Pretax Income 526,169 700,282 (1.35M) (3.25M) (1.25M)
Income Tax 152,000 185,000 (16,200) (875,992) 2.27M
Income Tax - Current Domestic 119,000 60,000 (176,500) (6,717) 0
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 33,000 175,000 (59,700) (869,275) 2.27M
Income Tax - Deferred Foreign 0 (50,000) 220,000 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 374,169 515,282 (1.34M) (2.38M) (3.52M)
Minority Interest Expense 0 0 0 0 0
Net Income 374,169 515,282 (1.34M) (2.38M) (3.52M)
Extraordinaries & Discontinued Operations 0 0 0 (3.76M) (19,194)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 (3.76M) (19,194)
Net Income After Extraordinaries 374,169 515,282 (1.34M) (6.14M) (3.54M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 374,169 515,282 (1.34M) (2.38M) (3.52M)
EPS (Basic) 0.14 0.19 (0.48) (2.21) (1.31)
Basic Shares Outstanding 2.68M 2.74M 2.79M 2.78M 2.71M
EPS (Diluted) 0.14 0.19 (0.48) (2.21) (1.31)
Diluted Shares Outstanding 2.68M 2.78M 2.79M 2.78M 2.71M
EBITDA 1.95M 2.03M 467,837 (320,946) 486,587
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Arrhythmia Research Technology Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 21.14M 23.36M 24.26M 20.64M 21.34M
Cost of Goods Sold (COGS) incl. D&A 17.56M 18.72M 19.65M 17.85M 18.31M
COGS excluding D&A 16.16M 17.34M 18.05M 16.43M 16.86M
Depreciation & Amortization Expense 1.39M 1.37M 1.6M 1.42M 1.44M
Depreciation - - - 1.41M 1.44M
Amortization of Intangibles - - - 7,056 4,840
Gross Income 3.58M 4.64M 4.61M 2.79M 3.03M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.03M 3.99M 5.74M 4.53M 3.99M
Research & Development 241,494 254,501 461,225 510,463 335,309
Other SG&A 2.79M 3.73M 5.28M 4.02M 3.65M
Other Operating Expense 0 0 0 0 0
Unusual Expense - 80,000 238,318 1.48M -
EBIT after Unusual Expense - (80,000) (238,318) (1.48M) -
Non Operating Income/Expense (9,325) 112,813 7,160 (9,319) 25,646
Non-Operating Interest Income 12,082 11,850 11,030 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 31,699 0 0 23,881 319,395
Gross Interest Expense 31,699 0 0 23,881 319,395
Interest Capitalized 0 - 0 0 0
Pretax Income 526,169 700,282 (1.35M) (3.25M) (1.25M)
Income Tax 152,000 185,000 (16,200) (875,992) 2.27M
Income Tax - Current Domestic 119,000 60,000 (176,500) (6,717) 0
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 33,000 175,000 (59,700) (869,275) 2.27M
Income Tax - Deferred Foreign 0 (50,000) 220,000 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 374,169 515,282 (1.34M) (2.38M) (3.52M)
Minority Interest Expense 0 0 0 0 0
Net Income 374,169 515,282 (1.34M) (2.38M) (3.52M)
Extraordinaries & Discontinued Operations 0 0 0 (3.76M) (19,194)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 (3.76M) (19,194)
Net Income After Extraordinaries 374,169 515,282 (1.34M) (6.14M) (3.54M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 374,169 515,282 (1.34M) (2.38M) (3.52M)
EPS (Basic) 0.14 0.19 (0.48) (2.21) (1.31)
Basic Shares Outstanding 2.68M 2.74M 2.79M 2.78M 2.71M
EPS (Diluted) 0.14 0.19 (0.48) (2.21) (1.31)
Diluted Shares Outstanding 2.68M 2.78M 2.79M 2.78M 2.71M
EBITDA 1.95M 2.03M 467,837 (320,946) 486,587
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
